Emergency Use Approval for Two Vaccines
India's drug regulator, Central Drugs Standard Control Organisation, has given emergency use authorisation (EUA) to Oxford- AstraZeneca’s Covishield and Bharat Biotech’s indigenously developed Covaxin. The subject expert committee (SEC) under CDSCO has recommended Covishield, for emergency use and Covaxin for restricted use.
Approved Vaccines
- Covishield is local name for the Oxford-AstraZeneca vaccine developed in the UK. It is being manufactured by Pune-based Serum Institute of India, the world's largest vaccine manufacturer. It is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus - although ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Novel Technique to Enhance Next-Gen Lighting
- 2 Majorana 1 Quantum Chip
- 3 Successful Wet Tests of Matsya-6000
- 4 Project Waterworth
- 5 Revolutionary Drug Delivery System for Rheumatoid Arthritis
- 6 DRDO Successfully Tests VSHORADS
- 7 Successful Test of Naval Anti-Ship Missile (NASM-SR)
- 8 Thermal & Magnetic Structure of Solar Coronal Holes
- 9 3D Structure of an Exoplanet’s Atmosphere Revealed
- 10 ESA’s Euclid Telescope Discovers Rare Einstein Ring
